Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database
1. University of Franche-Comté and CHU de Besan?on, Department of RheumatologyBesan?onFrancedwendling@chu-besancon.fr;3. AbbVie Inc.North Chicago, ILUSA;4. University of Illinois at ChicagoChicago, ILUSA